Mark S.

Mark S. is an experienced executive in the pharmaceutical industry, currently serving as Chief Operating Officer at Flynn Pharma since July 2015, focusing on business development and strategic growth for the company, which specializes in branded product commercialization in multiple healthcare markets. Prior to this, Mark held strategic roles at Innoture Medical Technology as Director of Commercial Operations, overseeing microneedle technology innovations, and at Sphinx Medical Ltd as Chief Executive Officer. Mark's extensive background includes leadership positions at Galen Limited, Nycomed, ALTANA AG, Quintiles, Roche Pharmaceuticals, and Syntex Pharmaceutical, showcasing a strong track record in sales, operations, and marketing across various global markets.